🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Ludwig Boltzmann - Institute for Applied Cancer Research
Start Date
1996-02
Trial ID
NCT00002904
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
This study seeks to determine if addition of trabectedin (T) to combination...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06
Trial ID
NCT03437070
Treatments Being Tested
Study is aimed at evaluating the activity of Trabectedin (arm A) in advance...
Status
Recruiting
Location
Azienda Ospedaliera S. Orsola-Malpighi
Start Date
2021-10-29
Trial ID
NCT04383119
Treatments Being Tested
Phase I-II trial that combines trabectedin plus radiotherapy for tumor redu...
Status
Recruiting
Location
Institut Bergonié
Start Date
2014-11
Trial ID
NCT02275286
Treatments Being Tested
To find out if receiving standard chemotherapy (doxorubicin and trabectedin...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-10-02
Trial ID
NCT07076186
Treatments Being Tested
The objective of LMS04 study is to better define the treatment strategy for...
Status
Completed
Location
Gustave Roussy
Start Date
2017-01-18
Trial ID
NCT02997358
Treatments Being Tested
The goal of this study is to build on the experience of the SAINT trial by ...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-06-12
Trial ID
NCT07444619
Treatments Being Tested
Phase I, multicentre clinical trial of olaratumab plus trabectedin in patie...
Status
Unknown
Location
GEIS
Start Date
2018-09-21
Trial ID
NCT03985722
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested